Protalix BioTherapeutics
PLX
#8935
Rank
โ‚น15.65 B
Marketcap
โ‚น194.25
Share price
1.00%
Change (1 day)
32.13%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): โ‚น1.74

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is โ‚น1.91. In 2024 the company made an earnings per share (EPS) of โ‚น3.83 a decrease over its 2023 EPS that were of โ‚น11.48.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น1.74-54.41%
2024โ‚น3.83-66.67%
2023โ‚น11.48-138.71%
2022-โ‚น29.66-50%
2021-โ‚น59.33181.82%
2020-โ‚น21.05-82.11%
2019-โ‚น117.70-31.67%
2018-โ‚น172.24-72.31%
2017-โ‚น621.99124.14%
2016-โ‚น277.50-147.54%
2015โ‚น583.71-290.63%
2014-โ‚น306.216.67%
2013-โ‚น287.07130.77%
2012-โ‚น124.40-69.77%
2011-โ‚น411.4719.44%
2010-โ‚น344.48-12.2%
2009-โ‚น392.3336.67%
2008-โ‚น287.07-37.5%
2007-โ‚น459.3150%
2006-โ‚น306.213.23%
2005-โ‚น296.64138.46%
2004-โ‚น124.40-74%
2003-โ‚น478.45-0%
2002-โ‚น478.45-50%
2001-โ‚น956.90233.33%
2000-โ‚น287.07-84.21%
1999-โ‚น1,818-24%
1998-โ‚น2,392-600%
1997โ‚น478.45-16.67%
1996โ‚น574.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.35 6,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น642.08 33,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-โ‚น10.53-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น131.10 6,750.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel